Last reviewed · How we verify
Difluprednate Ophthalmic Emulsion
Difluprednate Ophthalmic Emulsion is a Small molecule drug developed by Sirion Therapeutics, Inc.. It is currently FDA-approved.
At a glance
| Generic name | Difluprednate Ophthalmic Emulsion |
|---|---|
| Sponsor | Sirion Therapeutics, Inc. |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Difluprednate vs. a Prednisolone Acetate - Phenylephrine on Post-operative Inflammation Following Cataract Surgery. (PHASE4)
- Clinical Investigation of the Dextenza 0.4mg Intracanalicular Insert Delivery System Used in Cataract Surgery (PHASE4)
- Topical Corticosteroid Use in Addition to Oral Antivirals for Prevention of Recurrence of Herpes Simplex Virus (HSV) Keratitis (PHASE4)
- Macular Edema Nepafenac vs. Difluprednate Uveitis Trial (PHASE4)
- Clinical Study of the Efficacy of the Ophthalmic Emulsion PRO-145 for Inflammation and Pain After Phacoemulsification (PHASE3)
- Difluprednate Pediatric Study for the Treatment of Inflammation Post-Cataract Surgery (PHASE3)
- Evaluation of Anti-Inflammatory Treatment in Dry Eye Patients (PHASE2)
- Safety and Efficacy of Difluprednate 0.05% for the Treatment of Anterior Uveitis (PHASE3)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Difluprednate Ophthalmic Emulsion CI brief — competitive landscape report
- Difluprednate Ophthalmic Emulsion updates RSS · CI watch RSS
- Sirion Therapeutics, Inc. portfolio CI
Frequently asked questions about Difluprednate Ophthalmic Emulsion
What is Difluprednate Ophthalmic Emulsion?
Difluprednate Ophthalmic Emulsion is a Small molecule drug developed by Sirion Therapeutics, Inc..
Who makes Difluprednate Ophthalmic Emulsion?
Difluprednate Ophthalmic Emulsion is developed and marketed by Sirion Therapeutics, Inc. (see full Sirion Therapeutics, Inc. pipeline at /company/sirion-therapeutics-inc).
What development phase is Difluprednate Ophthalmic Emulsion in?
Difluprednate Ophthalmic Emulsion is FDA-approved (marketed).